Form 8-K - Current report:
SEC Accession No. 0000950170-22-020527
Filing Date
2022-10-31
Accepted
2022-10-31 08:03:56
Documents
17
Period of Report
2022-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clnn-20221031.htm   iXBRL 8-K 84576
2 EX-5.1 clnn-ex5_1.htm EX-5.1 19542
3 EX-10.1 clnn-ex10_1.htm EX-10.1 140171
4 EX-99.1 clnn-ex99_1.htm EX-99.1 25061
5 GRAPHIC img178974755_0.jpg GRAPHIC 16090
  Complete submission text file 0000950170-22-020527.txt   548369

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clnn-20221031.xsd EX-101.SCH 3328
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clnn-20221031_lab.xml EX-101.LAB 36065
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clnn-20221031_def.xml EX-101.DEF 28274
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clnn-20221031_pre.xml EX-101.PRE 29430
11 EXTRACTED XBRL INSTANCE DOCUMENT clnn-20221031_htm.xml XML 6627
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 221343829
SIC: 2834 Pharmaceutical Preparations